Realising the potential of correlates of protection for vaccine development, licensure and use: short summary

Deborah King; Helen Groves; Charlie Weller; Ian Jones; Jakob P. Cramer; Peter B Gilbert; David Goldblatt; Marion F. Gruber; Beate Kampmann; Diadié Maïga; Marcela F Pasetti; Stanley A. Plotkin; Alexander Roberto Precioso; Liya Wassie; Frederick Wittke; David C. Kaslow

doi:10.1038/s41541-024-00872-6

April 29, 2024npj VaccinesOpen Access

Realising the potential of correlates of protection for vaccine development, licensure and use: short summary

View Full Paper

Ask AI

Bookmark

Share

Key Points

To explore how correlates of protection can accelerate the vaccine development process and enhance licensure.
International multi-stakeholder workshop held on September 27–29, 2022.
Attended by 80 delegates including developers, manufacturers, regulators, and policy-makers.
Participants came from 17 countries, including 7 low- and middle-income countries (LMICs).
Identified strategies to utilize correlates of protection in vaccine development.
Facilitated dialogue among key stakeholders to align efforts in vaccine research and policy.
Emphasized the importance of CoP for regulatory approval and public health outcomes.

Implication

Workshop discusses using correlates of protection in vaccine development, highlighting its potential benefits.

Abstract

On 27–29th of September 2022, Wellcome convened an international multi-stakeholder workshop to discuss the use of Correlates of Protection (CoP) to accelerate vaccine development, the hybrid format meeting was attended by 80 delegates including developers, manufacturers, regulators, public health officials and policy-makers from 17 countries, including 7 LMIC’s.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

King et al. (2024) studied this question.

synapsesocial.com/papers/6a21bd8a40227a3dcbc0aebd https://doi.org/10.1038/s41541-024-00872-6

View Full Paper

Ask AI

Bookmark

Share

Realising the potential of correlates of protection for vaccine development, licensure and use: short summary

Key Points

Implication

Abstract

Discussion

Cite This Study

Realising the potential of correlates of protection for vaccine development, licensure and use: short summary

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading